THE APEX TIMES
The crypto exchange operator outlined plans to create prediction market contracts tailored for both retail and institutional traders, with a rollout targeted for the first half of 2027.
Coinbase is preparing to move further into “prediction markets,” a type of trading product that lets participants buy and sell contracts tied to the outcome of real-world events, and the company says it expects to bring its own US contracts to market in the first half of 2027.
In a report published Tuesday, Coinbase said it plans to launch prediction market contracts that it would issue itself, rather than relying solely on third-party offerings. The plan is aimed at both retail customers and institutional traders, according to the post.
Prediction market contracts generally function as event-linked instruments, where price reflects collective expectations about what will happen. While Coinbase did not provide in the report any additional specifications on contract design, settlement mechanics, or the range of events it would list, the company’s stated goal is to create a dedicated set of US contracts for trading.
The announcement also positions Coinbase as a more direct operator in the prediction market ecosystem. Instead of acting only as a venue where such instruments may be traded, issuing the contracts would place Coinbase in the role of product provider, which can affect how liquidity, listing decisions, and product terms are managed.
For Coinbase, the move comes amid a broader push across crypto and fintech toward permissioned, retail-friendly trading experiences, including products that resemble traditional market structures. Prediction markets are often discussed as a way to translate information about future outcomes into tradable prices, which could fit into a variety of speculative and hedging use cases.
The report does not spell out a launch path, including whether Coinbase will start with a limited number of contract types, whether it will partner with any existing prediction market operators, or what compliance or approvals would be required before trading begins in the United States.
It also remains unclear from the published post how Coinbase intends to structure access for institutions, such as whether institutional participants would trade through separate order types, dedicated market channels, or other bespoke arrangements.
What to watch next is whether Coinbase follows up with additional details, including contract scope, timelines within the first half of 2027, and any formal documentation describing how trading and settlement would work for its US prediction market contracts.
A market-focused note argues the company’s cash-return profile could matter as Wall Street debates whether 2027 can resemble 2022. The company, however, did not provide new disclosure in the cited post.
A market report said the U.S. Securities and Exchange Commission has opened an investigation involving Nvidia as the chipmaker absorbs fallout from a sharp selloff. Investors now have to parse what the agency is looking at and how much the matter could weigh on disclosures and governance.
A reported Phase 3 win for Moderna’s personalized melanoma therapy, used alongside Merck’s Keytruda, is prompting fresh optimism that the mRNA platform can expand beyond infectious disease. Still, key details such as magnitude of benefit and full trial disclosure remain to be validated.
Marques Brownlee said he has placed an order for Tesla’s Cybercab following a 2024 challenge, and Tesla CEO Elon Musk replied “fair enough,” saying he would accept delivery.
A new market read on Booz Allen Hamilton Holding points to a sizable gap between the company’s valuation and the cash flow the business can generate, sharpening questions for investors about how durable profits and cash generation are in the defense IT services market.
The company is pursuing Australian National Immunisation Program listings for its mRNA influenza vaccines after securing a March 2027 agenda spot with the PBAC, a key committee that advises public reimbursement.
A newly announced partnership between Microsoft and Danaher aims to pair AI-assisted capabilities with cloud-based scientific instruments and lab software, including early tools that are already moving toward commercial use.
A new market round-up from Yahoo Finance highlights how lingering discussion among Fed officials about whether interest rates need to rise again can reshape expectations for large, consumer-facing companies like PepsiCo.
The initiative, launched within Aetna, is designed to link a large share of expectant members and their newborns to coordinated maternal and infant care. CVS Health has not, in the reporting, disclosed staffing, clinical protocols, or outcome targets tied to the program.
A fresh round of holiday changes at Target centers on shopping hours and promotions, a shift the company is indicating as part of how it intends to drive demand into the end of the year.
Comments
Community guidelines. Comments may be removed for violations.
Loading comments...